Effect of astaxanthin on cataract formation induced by glucocorticoids in the chick embryo

Current Eye Research

Volumn 40, Issue 5, 2015, Pages 535-540

  Ishikawa, Sayano ^a   Hashizume, Kouhei ^a   Nishigori, Hideo ^a   Tezuka, Yu ^a   Sanbe, Atsushi ^a   Kurosaka, Daijiro ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

Astaxanthin; Cataract; Chick embryo; Glucocorticoid; Oxidative stress

Indexed keywords

ASTAXANTHIN; DIMETHYL SULFOXIDE; GLUCOCORTICOID; GLUCOSE; GLUTATHIONE; HYDROCORTISONE SODIUM SUCCINATE; SODIUM CHLORIDE; FIBRINOLYTIC AGENT; XANTHOPHYLL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATARACT; CATARACTOGENESIS; CHICK; CONTROLLED STUDY; DRUG EFFECT; EMBRYO; GLUCOSE BLOOD LEVEL; LENS; NONHUMAN; PRIORITY JOURNAL; ANIMAL; CHEMICALLY INDUCED; CHICK EMBRYO; DISEASE MODEL; DRUG EFFECTS; EMBRYOLOGY; METABOLISM; OXIDATIVE STRESS;

ANIMALS; CATARACT; CHICK EMBRYO; DISEASE MODELS, ANIMAL; FIBRINOLYTIC AGENTS; GLUCOCORTICOIDS; LENS, CRYSTALLINE; OXIDATIVE STRESS; XANTHOPHYLLS;

EID: 84926443128     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713683.2014.935445     Document Type: Article

References (46)

1. McCarty CA. Cataract in the 21st Century: lessons from previous epidemiological research. Clin Exp Optom 2002; 85:91-96.
2. Taylor HR, West SK, Rosenthal FS, Munoz B, Newland HS, Abbey H, et al. Effect of ultraviolet radiation on cataract formation. N Engl J Med 1988;319:1429-1433.
3. Hiller R, Giacometti L, Yuen K. Sunlight and cataract: an epidemiologic investigation. Am J Epidemiol 1977;105: 450-459.
4. Christen WG, Manson JE, Seddon JM, Glynn RJ, Buring JE, Rosner B, et al. A prospective study of cigarette smoking and risk of cataract in men. JAMA 1992;268:989-993.
5. West S, Munoz B, Emmett EA, Taylor HR. Cigarette smoking and risk of nuclear cataracts. Arch Ophthalmol 1989;107:1166-1169.
6. Hiller R, Sperduto RD, Podgor MJ, Wilson PW, Ferris 3rd FL, Colton T, et al. Cigarette smoking and the risk of development of lens opacities. The Framingham studies. Arch Ophthalmol 1997;115:1113-1118.
7. Hankinson SE, Willett WC, Colditz GA, Seddon JM, Rosner B, Speizer FE, et al. A prospective study of cigarette smoking and risk of cataract surgery in women. JAMA 1992;268:994-998.
8. Krishnaiah S, Vilas K, Shamanna BR, Rao GN, Thomas R, Balasubramanian D. Smoking and its association with cataract: results of the Andhra Pradesh eye disease study from India. Invest Ophthalmol Vis Sci 2005;46:58-65.
9. Kelly SP, Thornton J, Edwards R, Sahu A, Harrison R. Smoking and cataract: review of causal association. J Cataract Refract Surg 2005;31:2395-2404.
10. Jacques PF, Chylack LT. Epidemiologic evidence of a role for the antioxidant vitamins and carotenoids in cataract prevention. Am J Clin Nutr 1991;53: 352-355.
11. Varma SD. Scientific basis for medical therapy of cataracts by antioxidants. Am J Clin Nutr 1991;53:335-345.
12. Sies H. Oxidative stress: from basic research to clinical application. Am J Med 1991;91:31-38.
13. Miki W, Yamaguchi K, Konosu S. Comparison of carotenoids in the ovaries of marine fish and shellfish. Comp Biochem Physiol B 1982;71:7-11.
14. Higuera-Ciapara I, Félix-Valenzuela L, Goycoolea FM. Astaxanthin: a review of its chemistry and applications. Crit Rev Food Sci Nutr 2006;46:185-196.
15. Tanaka T, Makita H, Ohnishi M, Mori H, Satoh K, Hara A. Chemoprevention of rat oral carcinogenesis by naturally occurring xanthophylls, astaxanthin and canthaxanthin. Cancer Res 1995;55:4059-4064.
16. Fukuzawa K, Inokami Y, Tokumura A, Terao J, Suzuki A. Rate constants for quenching singlet oxygen and activities for inhibiting lipid peroxidation of carotenoids and alphatocopherol in liposomes. Lipids 1998;33:751-756.
17. Kobayashi M. In vivo antioxidant role of astaxanthin under oxidative stress in the green alga Haematococcus pluvialis. Appl Microbiol Biotechnol 2000;54:550-555.
18. Naguib YM. Antioxidant activities of astaxanthin and related carotenoids. J Agric Food Chem 2000;48:1150-1154.
19. Ohgami K, Shiratori K, Kotake S, Nishida T, Mizuki N, Yazawa K, et al. Effects of astaxanthin on lipopolysaccharide-induced inflammation in vitro and in vivo. Invest Ophthalmol Vis Sci 2003;44:2694-2701.
20. Suzuki Y, Ohgami K, Shiratori K, Jin X, llieva L, Koyama Y, et al. Suppressive effects of astaxanthin against rat endotoxin-induced uveitis by inhibiting the NF-kB signaling pathway. Exp Eye Res 2006;82:275-281.
21. Lee SJ, Bai SK, Lee KS, Namkoong S, Na HJ, Ha KS, et al. Astaxanthin inhibits nitric oxide production and inflammatory gene expression by suppressing I(kappa)B kinasedependent NF-kappaB activation. Mol Cells 2003;16: 97-105.
22. Guerin M, Huntley ME, Olaizola M. Haematococcus astaxanthin: applications for human health and nutrition. Trends Biotechnol 2003;21:210-216.
23. Chew BP, Park JS, Wong MW, Wong TS. A comparison of the anticancer activities of dietary beta-carotene, canthaxanthin and astaxanthin in mice in vivo. Anticancer Res 1999;19:1849-1853.
24. Naito Y, Uchiyama K, Aoi W, Hasegawa G, Nakamura N, Yoshida N, et al. Prevention of diabetic nephropathy by treatment with astaxanthin in diabetic db/db mice. Biofactors 2004;20:49-59.
25. Krinsky NI. Antioxidant functions of carotenoids. Free Radic Biol Med 1989;7:617-635.
26. Naguib YM. Antioxidant activities of astaxanthin and related carotenoids. J Agric Food Chem 2000;48:1150-1154.
27. Nishigori H, Lee JW, Iwatsuru M. An animal model for cataract research: cataract formation in developing chick embryo by glucocorticoid. Exp Eye Res 1983;36:617-621.
28. Nishigori H, Kosano H, Umeda IO, Nishigori H. Inhibition of glucocorticoid-induced cataracts in chick embryos by RU486: a model for studies on the role of glucocorticoids in development. Life Sci 2004;75:3027-3033.
29. Lee JW, Iwatsuru M, Nishigori H. Alteration of activities of hepatic antioxidant defence enzymes in developing chick embryos after glucocorticoid administration-a factor to produce some adverse effects? J Pharm Pharmacol 1998;50: 655-660.
30. Kosano H, Watanabe H, Nishigori H. Suppressive effects of thyroxine on glucocorticoid (gc)-induced metabolic changes and cataract formation on developing chick embryos. Exp Eye Res 2001;72:643-648.
31. Nishigori H, Hayashi R, Lee JW, Maruyama K, Iwatsuru M. Preventive effect of ascorbic acid against glucocorticoid-induced cataract formation of developing chick embryos. Exp Eye Res 1985;40:445-451.
32. Murakami I, Kosano H, Ogihara-Umeda I, Nishigori H, Uga S, Ishikawa S. Comparison of lens biochemistry and structure between BSO-treated and glucocorticoidtreated developing chick embryos. Exp Eye Res 1996;63: 673-681.
33. Nishigori H, Yasunaga M, Mizumura M, Lee JW, Iwatsuru M. Preventive effects of pyrroloquinoline quinone on formation of cataract and decline of lenticular and hepatic glutathione of developing chick embryo after glucocorticoid treatment. Life Sci 1989;45:593-598.
34. Nishigori H, Hayashi R, Lee JW, Iwatsuru M. Effect of MPG on glucocorticoid-induced cataract formation in developing chick embryo. Invest Ophthalmol Vis Sci 1984;25:1051-1055.
35. Setogawa T, Kosano H, Ogihara-Umeda I, Kayanuma T, Nishigori H. Preventive effect of SA3443, a novel cyclic disulfide, on glucocorticoid-induced cataract formation of developing chick embryo. Exp Eye Res 1994;58:689-695.
36. Nishigori H, Lee JW, Iwatsuru M. An animal model for cataract research: cataract formation in developing chick embryo by glucocorticoid. Exp Eye Res 1983;36:617-621.
37. Lee JW, Iwatsuru M, Nishigori H. Glucocorticoid-induced cataract of developing chick embryo as a screening model for anticataract agents. J Ocul Pharmacol Ther 1995;11: 533-541.
38. Waagb R, Hamre K, Bjerkas E, Berge R, Wathne E, Lie O, et al. Cataract formation in Atlantic salmon, Salmo salar L., smolt relative to dietary pro-and antioxidants and lipid level. J Fish Dis 2003;26:213-229.
39. Liao JH, Chen CS, Maher TJ, Liu CY, Lin MH, Wu TH, et al. Astaxanthin interacts with selenite and attenuates seleniteinduced cataractogenesis. Chem Res Toxicol 2009;22: 518-525.
40. Kawada H, Kojima M, Kimura T, Natori S, Sasaki K, Sasaki H. Effect of 5-S-GAD on UV-B-induced cataracts in rats. Jpn J Ophthalmol 2009;53:531-535.
41. Nishigori H, Lee JW, Yamauchi Y, Iwamatsu M. Elevation of glucose in ocular compartments of developing chick embryos with glucocorticoid-induced cataract. Exp Eye Res 1989;49:515-522.
42. Watanabe H, Kosano H, Nishigori H. Steroid-induced short term diabetes in chick embryo: reversible effects of insulin on metabolic changes and cataract formation. Invest Ophthalmol Vis Sci 2000;41:1846-1852.
43. Bhuvaneswari S, Anuradha CV. Astaxanthin prevents loss of insulin signaling and improves glucose metabolism in liver of insulin resistant mice. Can J Physiol Pharmacol 2012;90:1544-1552.
44. Hashimoto H, Arai K, Hayashi S, Okamoto H, Takahashi J, Chikuda M, et al. Effects of astaxanthin on antioxidation in human aqueous humor. J Clin Biochem Nutr 2013;53:1-7.
45. Sanmartín-Suárez C, Soto-Otero R, Sánchez-Sellero I, Méndez-Álvarez E. Antioxidant properties of dimethyl sulfoxide and its viability as a solvent in the evaluation of neuroprotective antioxidants. J Pharmacol Toxicol Methods 2011;63:209-215.
46. Srbye H, Guttu K, Gislason H, Grong K, Svanes K. Gastric mucosal injury and associated changes in mucosal blood flow and gastric fluid secretion caused by dimethyl sulfoxide (DMSO) in rats. Dig Dis Sci 1993;38:1243-1250.